Apellis Pharmaceuticals, Inc.
NASDAQ:APLS
28.56 (USD) • At close November 4, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| -528.628 | -652.172 | -746.354 | -344.874 | -304.707 | -127.502 | -51.006 | -27.125 | -46.516 | -10.788 | -3.962 |
| Afschrijvingen & Amortisatie
| 1.704 | 1.487 | 1.492 | 0.637 | 0.24 | 0 | 0.012 | 0 | 0 | 0.007 | 0.006 |
| Uitgestelde Inkomstenbelasting
| -368.545 | 0 | 198.264 | 103.029 | 16.34 | 0 | 0.154 | 0 | 0 | 0 | -0.272 |
| Aandelen Gebaseerde Vergoedingen
| 105.945 | 91.085 | 70.667 | 45.376 | 21.144 | 7.733 | 5.419 | 1.079 | 0.546 | 0.659 | 0.272 |
| Verandering in Werkkapitaal
| -200.169 | -15.698 | -93.522 | 19.586 | 53.15 | -12.04 | -1.187 | 0.043 | 0.628 | 0.175 | 0.239 |
| Vorderingen
| -198.715 | 2.375 | -10.103 | 0 | 0 | 0 | 0 | 0 | 0 | 0.045 | 0.04 |
| Voorraden
| -60.647 | -69.397 | -16.317 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Crediteuren
| 0.17 | 18.689 | 10.487 | -0.054 | -1.641 | 6.587 | 0.932 | 0.07 | 1.726 | 0.398 | 0.22 |
| Overig Werkkapitaal
| 59.023 | 32.635 | -77.589 | 19.64 | 54.79 | -18.628 | -2.119 | -0.027 | -1.098 | -0.223 | 0.019 |
| Overige Niet-Contante Posten
| 394.958 | 61.553 | 6.327 | 15.758 | 2.698 | 0.568 | 0.014 | 1.009 | 26.486 | 0.001 | 0.272 |
| Kasstroom uit Operationele Activiteiten
| -594.735 | -513.745 | -563.126 | -160.488 | -211.135 | -131.241 | -46.595 | -26.003 | -18.856 | -9.947 | -3.445 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -0.773 | -1.524 | -1.103 | -5.422 | -1.693 | 0 | 0 | 0 | 0 | -0.02 | 0 |
| Netto Overnames
| 0.099 | -61.417 | -248.719 | 311.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | -331.863 | -171.281 | -879.067 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 393.28 | 420 | 567.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0.099 | 61.417 | 248.719 | -311.567 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| -0.674 | 59.893 | 247.616 | -316.989 | -1.693 | 0 | 0 | 0 | 0 | -0.02 | 0 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| 0 | 0 | 0 | -322.874 | -28.701 | 0 | -26.365 | 0 | 0 | 0 | -0.275 |
| Uitgifte van Gewone Aandelen
| 461.039 | 380.12 | 398.024 | 381.423 | 109.581 | 131.194 | 150.063 | 14.863 | 0.002 | 0 | 0 |
| Terugkoop van Gewone Aandelen
| -11.04 | 4.238 | -1.788 | 1.575 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 405.539 | -18.699 | 394.024 | 954.928 | 307.662 | 0.709 | 47.312 | 14.863 | 41.235 | 18.831 | 7.436 |
| Kasstroom uit Financieringsactiviteiten
| 394.499 | 365.659 | 392.236 | 692.178 | 388.541 | 131.903 | 197.375 | 14.863 | 41.236 | 18.831 | 7.162 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0.135 | -0.488 | -2.016 | 0.359 | 0.005 | -0.038 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| -200.775 | -88.681 | 74.71 | 215.06 | 175.717 | 0.624 | 150.78 | -11.14 | 22.381 | 8.865 | 3.717 |
| Kaspositie aan het Einde van de Periode
| 352.299 | 553.074 | 641.755 | 567.045 | 351.985 | 176.268 | 175.644 | 24.863 | 36.004 | 13.623 | 4.758 |